Found 7 matching trials
18F-FSPG PET/CT for Cancer Patients on Therapy PHASE2 The goal of this phase 2 study trial is to evaluate the utility of the radi...
Show More Location
Stanford University Medical Center
Learn More & Join Trial
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules PHASE2 This clinical trial compares fluorine F 18 L-glutamate derivative BAY94-939...
Show More Location
Tennessee Valley Health System Nashville
Learn More & Join Trial
Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer PHASE1 The study will be conducted as an open label, single-dose, explorative stud...
Show More Location
Multiple Locations
Learn More & Join Trial
Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation PHASE1 Visual assessment of diagnostic PET/CT (positron emission tomography/comput...
Show More Location
Multiple Locations
Learn More & Join Trial
Glutamine PET Imaging Colorectal Cancer PHASE1 The clinical trial studies how well 11C-glutamine and 18F-FSPG positron emi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules PHASE2 This phase II trial studies how well 18F-FSPG positron emission tomography ...
Show More Location
Stanford Cancer Institute Palo Alto
Learn More & Join Trial
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant PHASE1 This clinical trial studies fluorine F 18 L-glutamate derivative BAY94-9392...
Show More Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Learn More & Join Trial